Pooled Analysis of Clinical Outcome of Patients with Chemorefractory Metastatic Colorectal Cancer Treated within Phase I/II Clinical Studies Based on Individual Biomarkers of Susceptibility: A Single-Institution Experience

BACKGROUND: Patients with metastatic colorectal cancer (mCRC) refractory to standard therapies have a poor prognosis. In this setting, recruitment into clinical trials is warranted, and studies driven by selection according to individual tumor molecular characteristics are expected to provide added...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Target Oncol
Main Authors: Sartore-Bianchi, Andrea, Amatu, Alessio, Bonazzina, Erica, Stabile, Stefano, Giannetta, Laura, Cerea, Giulio, Schiavetto, Ilaria, Bencardino, Katia, Funaioli, Chiara, Ricotta, Riccardo, Cipani, Tiziana, Schirru, Michele, Gambi, Valentina, Palmeri, Laura, Carlo-Stella, Giulia, Rusconi, Francesca, Di Bella, Sara, Burrafato, Giovanni, Cassingena, Andrea, Valtorta, Emanuele, Lauricella, Calogero, Pazzi, Federica, Gambaro, Alessandra, Ghezzi, Silvia, Marrapese, Giovanna, Tarenzi, Emiliana, Veronese, Silvio, Truini, Mauro, Vanzulli, Angelo, Siena, Salvatore
Formato: Artigo
Idioma:Inglês
Publicado em: Springer International Publishing 2017
Assuntos:
Original Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5524857/
https://ncbi.nlm.nih.gov/pubmed/28669023
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11523-017-0505-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados